CyclophosphamideVarious toxicities and off-label use: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1943卷 / 1期

关键词：

D O I：

10.1007/s40278-023-33129-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：244 / 244

相关论文

共 50 条

[1] RituximabVarious toxicities and off-label use: 3 case reports
Reactions Weekly, 2023, 1940 (1) : 374 - 374
[2] DasatinibVarious toxicities following off-label use: 3 case reports
Reactions Weekly, 2021, 1881 (1) : 92 - 92
[3] MethotrexateVarious toxicities followed by off-label use: 3 case reports
Reactions Weekly, 2023, 1980 (1) : 244 - 244
[4] PazopanibVarious toxicities following off-label use: 3 case reports
Reactions Weekly, 2023, 1939 (1) : 375 - 375
[5] RituximabVarious toxicities following an off-label use: 3 case reports
Reactions Weekly, 2018, 1683 (1) : 600 - 600
[6] BlinatumomabVarious toxicities followed by off-label use: 3 case reports
Reactions Weekly, 2022, 1930 (1) : 136 - 136
[7] Lenvatinib/sunitinibVarious toxicities and off-label use: 3 case reports
Reactions Weekly, 2022, 1905 (1) : 278 - 278
[8] Golimumab/infliximabVarious toxicities and off-label use: 3 case reports
Reactions Weekly, 2023, 1986 (1) : 194 - 194
[9] BelantamabVarious toxicities following off-label use: 3 case reports
Reactions Weekly, 2023, 1961 (1) : 96 - 96
[10] BlinatumomabVarious toxicities following off-label use: 3 case reports
Reactions Weekly, 2020, 1809 (1) : 74 - 74

← 1 2 3 4 5 →